Gilde Healthcare is a Dutch investor with separate funds for venture-stage health companies and for established healthcare businesses, backing diagnostics, medical technology and therapeutics across Europe and the United States.
Gilde Healthcare is a specialist healthcare investor headquartered in Utrecht with offices in Frankfurt and Boston, running a venture and growth strategy for therapeutics, medtech, diagnostics and digital health alongside a private equity strategy for profitable healthcare services companies. Its oncology exposure runs through diagnostics and device companies as well as drug developers; portfolio links in OnCo are derived from the startup records that name it.
| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Adcendo Copenhagen, DK | Growth stage | biotech | Sarcomas (soft tissue, bone, GIST) | Series C 2026, $75M |
| GT Medical Technologies Tempe, AZ, US | Growth stage | devices | Glioma & glioblastoma | Series E 2026, $100M |
Shares Adcendo and the tag vc.
Shares Adcendo and the tag vc.
Shares Adcendo and the tag vc.
Shares Adcendo and the tag vc.
Shares Adcendo and the tag vc.
Shares Adcendo and the tag vc.
Shares Adcendo and the tag vc.
Shares Adcendo and the tag vc.